AUTOMATED AI SCREENING FOR DIABETIC RETINOPATHY: A SYSTEMATIC REVIEW OF SOCIO-ECONOMIC ACCESSIBILITY, PATIENT ACCEPTANCE, AND THE DIGITAL DIVIDE
Open Access
- 26 March 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Abstract
Purpose: This systematic review evaluates the socio-technical integration of autonomous artificial intelligence (AI) in diabetic retinopathy (DR) screening. While the technical accuracy of deep learning algorithms is well-established, their successful deployment depends on a complex interplay of economic, psychological, and organizational factors. This study synthesizes evidence from 35 peer-reviewed sources to provide a comprehensive roadmap for AI implementation in diverse healthcare settings. Methods: A systematic analysis of 35 high-quality studies (2017–2026) was conducted, focusing on diagnostic performance, cost-effectiveness, and stakeholder acceptance. The findings were interpreted through the Consolidated Framework for Implementation Research (CFIR) to identify systemic barriers and facilitators. Results: The evidence confirms that autonomous AI reaches high sensitivity (95.7%–100%) in detecting referable DR, matching specialist performance. Economically, AI is highly cost-effective in resource-limited and rural areas by reducing travel costs and labor burdens. However, significant barriers remain, including the "biological divide" in elderly populations, "black box" anxiety among patients, and organizational disruption in primary care workflows. Trust is identified as a critical mediator, with acceptance increasing when AI is positioned as a supportive "safety net" rather than a human replacement. Conclusion: The transition to AI-driven screening is a transformative shift toward democratized healthcare. Success requires a move toward Human-Centered Design (HCD), localized staff education using tools like instructional videos, and inclusive governance to bridge the digital divide.Keywords
This publication has 35 references indexed in Scilit:
- Autonomous Artificial Intelligence in Diabetic Retinopathy Testing—Lessons Learned on Successful Health System AdoptionOphthalmology Science, 2025
- Healthcare providers’ perceptions of artificial intelligence in diabetes care: A cross-sectional study in ChinaInternational Journal of Nursing Sciences, 2025
- Acceptability, applicability, and cost-utility of artificial-intelligence-powered low-cost portable fundus camera for diabetic retinopathy screening in primary health care settingsDiabetes Research and Clinical Practice, 2025
- Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening CommitteeThe Lancet Digital Health, 2025
- Patient and practitioner perceptions around use of artificial intelligence within the English NHS diabetic eye screening programmeDiabetes Research and Clinical Practice, 2024
- Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening casenpj Digital Medicine, 2024
- Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysiseClinicalMedicine, 2024
- Impact of Artificial Intelligence Assessment of Diabetic Retinopathy on Referral Service Uptake in a Low-Resource SettingOphthalmology Science, 2022
- Feasibility and patient acceptability of a novel artificial intelligence-based screening model for diabetic retinopathy at endocrinology outpatient services: a pilot studyScientific Reports, 2018
- Automated Diabetic Retinopathy Image Assessment SoftwareOphthalmology, 2017